Detalhe da pesquisa
1.
SnapShot: Cancer Immunotherapy with Oncolytic Viruses.
Cell
; 176(5): 1240-1240.e1, 2019 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30794777
2.
Optimal delivery of RNA interference by viral vectors for cancer therapy.
Mol Ther
; 31(11): 3127-3145, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37735876
3.
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Mol Ther
; 31(11): 3176-3192, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37766429
4.
Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen.
Mol Ther
; 30(9): 2998-3016, 2022 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35526097
5.
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Mol Ther
; 30(5): 1885-1896, 2022 05 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34687845
6.
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry.
Mol Ther
; 29(6): 1984-2000, 2021 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33578036
7.
Safety and efficacy of autologous whole cell vaccines in hematologic malignancies: A systematic review and meta-analysis.
Hematol Oncol
; 39(4): 448-464, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33963789
8.
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Int J Mol Sci
; 22(5)2021 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-33668756
9.
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis.
PLoS Pathog
; 14(8): e1007264, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30138450
10.
Enhancement of oncolytic virotherapy by vanadium(V) dipicolinates.
Biometals
; 32(3): 545-561, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31209680
11.
Multi-modal Potentiation of Oncolytic Virotherapy by Vanadium Compounds.
Mol Ther
; 26(1): 56-69, 2018 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29175158
12.
Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma.
Int J Cancer
; 141(6): 1257-1264, 2017 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28568891
13.
Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.
Nature
; 477(7362): 99-102, 2011 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-21886163
14.
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.
Breast Cancer Res
; 18(1): 83, 2016 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27503504
15.
From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer.
PLoS Pathog
; 10(1): e1003836, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24453963
16.
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma.
J Virol
; 87(4): 2363-6, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23221568
17.
HDAC inhibition suppresses primary immune responses, enhances secondary immune responses, and abrogates autoimmunity during tumor immunotherapy.
Mol Ther
; 21(4): 887-94, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23295947
18.
Immune profiling of dedifferentiated liposarcoma and identification of novel antigens for targeted immunotherapy.
Sci Rep
; 14(1): 11254, 2024 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38755218
19.
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways.
Nat Commun
; 15(1): 4096, 2024 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38750019
20.
The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.
Mol Ther
; 20(4): 749-58, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22186794